BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 26132858)

  • 1. Natural Products for the Treatment of Type 2 Diabetes Mellitus.
    Ríos JL; Francini F; Schinella GR
    Planta Med; 2015 Aug; 81(12-13):975-94. PubMed ID: 26132858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity.
    Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K
    J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Prenylchalconaringenins and Prenylnaringenins as Antidiabetic Agents: α-Glucosidase and α-Amylase Inhibition and in Vivo Antihyperglycemic and Antihyperlipidemic Effects.
    Sun H; Wang D; Song X; Zhang Y; Ding W; Peng X; Zhang X; Li Y; Ma Y; Wang R; Yu P
    J Agric Food Chem; 2017 Mar; 65(8):1574-1581. PubMed ID: 28132506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.
    Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF
    Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
    Riyaphan J; Pham DC; Leong MK; Weng CF
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of AMPK by Medicinal Plants and Natural Products: Its Role in Type 2 Diabetes Mellitus.
    Francini F; Schinella GR; Ríos JL
    Mini Rev Med Chem; 2019; 19(11):880-901. PubMed ID: 30484403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of α-glucosidase and α-amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays.
    Tolmie M; Bester MJ; Apostolides Z
    J Diabetes; 2021 Oct; 13(10):779-791. PubMed ID: 33550683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.
    Joshi SR; Standl E; Tong N; Shah P; Kalra S; Rathod R
    Expert Opin Pharmacother; 2015; 16(13):1959-81. PubMed ID: 26255950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
    Hedrington MS; Davis SN
    Expert Opin Pharmacother; 2019 Dec; 20(18):2229-2235. PubMed ID: 31593486
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
    McCue P; Kwon YI; Shetty K
    Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal Medicines for Diabetes Management and its Secondary Complications.
    Kumar S; Mittal A; Babu D; Mittal A
    Curr Diabetes Rev; 2021; 17(4):437-456. PubMed ID: 33143632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2).
    Abbas G; Al Harrasi A; Hussain H; Hamaed A; Supuran CT
    Bioorg Chem; 2019 May; 86():305-315. PubMed ID: 30738330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Alkaloids and Diabetes Mellitus: A Review.
    Ajebli M; Khan H; Eddouks M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(1):111-130. PubMed ID: 32955004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal plants of Southeast Asia with anti-α-glucosidase activity as potential source for type-2 diabetes mellitus treatment.
    Benjamin MAZ; Mohd Mokhtar RA; Iqbal M; Abdullah A; Azizah R; Sulistyorini L; Mahfudh N; Zakaria ZA
    J Ethnopharmacol; 2024 Aug; 330():118239. PubMed ID: 38657877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymes inhibitors from natural sources with antidiabetic activity: A review.
    Alam F; Shafique Z; Amjad ST; Bin Asad MHH
    Phytother Res; 2019 Jan; 33(1):41-54. PubMed ID: 30417583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of Phenolic Compounds Reveals Inhibitory Activity of Nordihydroguaiaretic Acid Against Three Enzymes Involved in the Regulation of Blood Glucose Level.
    Roškar I; Štrukelj B; Lunder M
    Plant Foods Hum Nutr; 2016 Mar; 71(1):88-9. PubMed ID: 26860525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of bioactive compounds with acarbose: A proposal to control hyperglycemia in type 2 diabetes.
    Uuh Narvaez JJ; Segura Campos MR
    J Food Biochem; 2022 Oct; 46(10):e14268. PubMed ID: 35662051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Updated Overview of Synthetic α-glucosidase Inhibitors: Chemistry and Bioactivities.
    Cai YS; Xie HX; Zhang JH; Li Y; Zhang J; Wang KM; Jiang CS
    Curr Top Med Chem; 2023; 23(26):2488-2526. PubMed ID: 37818579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.